Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Asia-Pacific cell line development market industry 360⁰ synopsis, 2016 – 2027

Chapter 3   Asia-Pacific Cell Line Development Market Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Growing vaccine production

3.3.1.2    Increasing cancer prevalence

3.3.1.3    Growth in biotechnology industry

3.3.1.4    Innovations in biologics due to patent expirations

3.3.1.5    Rising demand for monoclonal antibodies

3.3.1.6    Technological innovation in cell line development

3.3.2    Industry pitfalls & challenges

3.3.2.1    Issues related to stem cell research

3.3.2.2    Variable reimbursement scenario

3.4    Competitive review, 2020

3.5    Porter’s analysis

3.6    PEST analysis

Chapter 4   Asia-Pacific Cell Line Development Market, By Product

4.1    Key segment trends

4.2    Reagents & media

4.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

4.3    Equipment

4.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

4.3.2    Incubators

4.3.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

4.3.3    Centrifuges

4.3.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

4.3.4    Bioreactors

4.3.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

4.3.5    Storage equipment

4.3.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

4.3.6    Microscopes

4.3.6.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

4.4    Accessories & consumables

4.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

Chapter 5   Asia-Pacific Cell Line Development Market, By Source

5.1    Key segment trends

5.2    Mammalian

5.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

5.3    Non-mammalian

5.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

5.3.2    Insects

5.3.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

5.3.3    Amphibians

5.3.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

Chapter 6   Asia-Pacific Cell Line Development Market, By Cell Line Type

6.1    Key segment trends

6.2    Recombinant cell lines

6.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.3    Hybridomas

6.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.4    Continuous cell lines

6.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

6.5    Primary cell lines

6.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

Chapter 7   Asia-Pacific Cell Line Development Market, By Application

7.1    Key segment trends

7.2    Bioproduction

7.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

7.3    Drug discovery

7.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

7.4    Toxicity testing

7.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

7.5    Tissue engineering

7.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

7.6    Research

7.6.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

Chapter 8   Asia-Pacific Cell Line Development Market, By Country

8.1    Key country trends

8.2    Asia-Pacific

8.2.1    Market size by country, 2016 - 2027 (USD Million)

8.2.2    Market size by product, 2016 - 2027 (USD Million)

8.2.3    Market size by source, 2016 - 2027 (USD Million)

8.2.4    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.5    Market size by application, 2016 - 2027 (USD Million)

8.2.6    Japan

8.2.6.1    Market size by product, 2016 - 2027 (USD Million)

8.2.6.2    Market size by source, 2016 - 2027 (USD Million)

8.2.6.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.6.4    Market size by application, 2016 - 2027 (USD Million)

8.2.7    China

8.2.7.1    Market size by product, 2016 - 2027 (USD Million)

8.2.7.2    Market size by source, 2016 - 2027 (USD Million)

8.2.7.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.7.4    Market size by application, 2016 - 2027 (USD Million)

8.2.8    India

8.2.8.1    Market size by product, 2016 - 2027 (USD Million)

8.2.8.2    Market size by source, 2016 - 2027 (USD Million)

8.2.8.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.8.4    Market size by application, 2016 - 2027 (USD Million)

8.2.9    Australia

8.2.9.1    Market size by product, 2016 - 2027 (USD Million)

8.2.9.2    Market size by source, 2016 - 2027 (USD Million)

8.2.9.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.9.4    Market size by application, 2016 - 2027 (USD Million)

8.2.10    South Korea

8.2.10.1    Market size by product, 2016 - 2027 (USD Million)

8.2.10.2    Market size by source, 2016 - 2027 (USD Million)

8.2.10.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.10.4    Market size by application, 2016 - 2027 (USD Million)

8.2.11    Malaysia

8.2.11.1    Market size by product, 2016 - 2027 (USD Million)

8.2.11.2    Market size by source, 2016 - 2027 (USD Million)

8.2.11.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.11.4    Market size by application, 2016 - 2027 (USD Million)

8.2.12    Indonesia

8.2.12.1    Market size by product, 2016 - 2027 (USD Million)

8.2.12.2    Market size by source, 2016 - 2027 (USD Million)

8.2.12.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.12.4    Market size by application, 2016 - 2027 (USD Million)

8.2.13    Thailand

8.2.13.1    Market size by product, 2016 - 2027 (USD Million)

8.2.13.2    Market size by source, 2016 - 2027 (USD Million)

8.2.13.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.13.4    Market size by application, 2016 - 2027 (USD Million)

8.2.14    Singapore

8.2.14.1    Market size by product, 2016 - 2027 (USD Million)

8.2.14.2    Market size by source, 2016 - 2027 (USD Million)

8.2.14.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.14.4    Market size by application, 2016 - 2027 (USD Million)

8.2.15    Taiwan

8.2.15.1    Market size by product, 2016 - 2027 (USD Million)

8.2.15.2    Market size by source, 2016 - 2027 (USD Million)

8.2.15.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.15.4    Market size by application, 2016 - 2027 (USD Million)

8.2.16    Philippines

8.2.16.1    Market size by product, 2016 - 2027 (USD Million)

8.2.16.2    Market size by source, 2016 - 2027 (USD Million)

8.2.16.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.16.4    Market size by application, 2016 - 2027 (USD Million)

8.2.17    Vietnam

8.2.17.1    Market size by product, 2016 - 2027 (USD Million)

8.2.17.2    Market size by source, 2016 - 2027 (USD Million)

8.2.17.3    Market size by cell line type, 2016 - 2027 (USD Million)

8.2.17.4    Market size by application, 2016 - 2027 (USD Million)

Chapter 9   Company Profiles

9.1    GE Healthcare

9.1.1    Business overview

9.1.2    Financial data

9.1.3    Product landscape

9.1.4    Strategic outlook

9.2    Thermo Fisher Scientific Inc.

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.2.4    Strategic outlook

9.3    Lonza Group AG

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.4    Sigma-Aldrich Corporation (Merck)

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.5    WuXi AppTec

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.6    Sartorius Stedim Biotech GmbH

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.7    Samsung Biologics

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook

9.8    EuBiologics

9.8.1    Business overview

9.8.2    Financial data

9.8.3    Product landscape

9.8.4    Strategic outlook

9.9    GVK BIO

9.9.1    Business overview

9.9.2    Financial data

9.9.3    Product landscape

9.9.4    Strategic outlook

9.10    Selexis SA

9.10.1    Business overview

9.10.2    Financial data

9.10.3    Product landscape

9.10.4    Strategic outlook

9.11    Corning

9.11.1    Business overview

9.11.2    Financial data

9.11.3    Product landscape

9.11.4    Strategic outlook

9.12    Patheon

9.12.1    Business overview

9.12.2    Financial data

9.12.3    Product landscape

9.12.4    Strategic outlook